Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-128

But it isn't a diagnosis app, it's a screening tool and will be used as DTC by users who are curious if they have OSA or diet improvement have lower their risk, hence it's only $8....IMO, it can potentially bring in $4-6M globally in revenue as a DTC product which is reasonably good but not massive revenue until big companies are on board with their connection which will need SleepCheck classify as a diagnosis tool.